BridgeBio Oncology Therapeutics, Inc.
BBOT· Nasdaq
BridgeBio Oncology Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -1.65%
- Market cap
- $311.08M
- 80.17M shares
- Filings
- 179
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $121,199,000 | reported | |
| FY 2024 | 2024-12-31 | $73,107,000 | reported |
BridgeBio Oncology Therapeutics, Inc. · CIK 1869105 · Engraved from SEC EDGAR
